# A Cohort Study to Compare the Hospitalization Between Naive Sacubitril/Valsartan and Naive ACEi/ARBs Heart Failure Patients With Reduced Ejection Fraction Using Secondary US Electronic Health Records Data

> **NCT05096143** · — · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 42269 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Sacubitril/valsartan
- **DRUG:** ACEi/ARB

## Key facts

- **NCT ID:** NCT05096143
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-03
- **Primary completion:** 2020-10-19
- **Final completion:** 2020-10-19
- **Target enrollment:** 42269 (ACTUAL)
- **Last updated:** 2021-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05096143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05096143, "A Cohort Study to Compare the Hospitalization Between Naive Sacubitril/Valsartan and Naive ACEi/ARBs Heart Failure Patients With Reduced Ejection Fraction Using Secondary US Electronic Health Records Data". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05096143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*